Status: Recruiting
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
The primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type, compared with placebo.
Participants needed: 150
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Teikoku Pharma USA, Inc.Updated: Jul 2, 2026Locations: 6
Eligibility criteria
Voluntarily provide written informed consent (subject or legally authorized repr... [+12]
Has a known sensitivity to dexmedetomidine or any excipient in the DMTS/placebo. [+21]